Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

The European Medicines Evaluation Agency: role of experts in drug assessment

Article Abstract:

The European Medicines Evaluation Agency (EMEA) and a new European system for the authorization of pharmaceutical products have been established. The objectives and tasks of the EMEA cover several areas such as product safety and efficacy, singular evaluation process, product authorization and surveillance, access to innovative therapy and drugs, information campaign, consumer protection and pharmaceutical research. A balanced representation of pharmacology experts from Member States has also been ensured.

Author: Benzi, Gianni
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1995
Evaluation, Europe, Drugs, Associations, European Union, Drug evaluation, Drug approval, Pharmacologists

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Genetic approaches to drug dependence

Article Abstract:

The possibility that drug dependence may be partly due to underlying genetic factors motivated the breeding of animals with homozygous gene loci. Lines of sensitized and unsensitized animals were developed by inbreeding for several generations. In the process, the importance of genetic factors to the chosen trait is visibly underlined. Genetic mapping aids in correlating certain gene loci with the chosen trait to be studied and provides an insight on the relationship of gene and drug abuse trait.

Author: Crabbe, John C., Belknap, John K.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1992
Psychological aspects, Research, Physiological aspects, Genetic aspects, Alcoholism, Substance abuse, Drug abuse, Animal genetic engineering, Pharmacogenetics, Pharmacogenomics, Dopaminergic mechanisms, Behavioral toxicology

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Protease-mediated signalling: new paradigms for cell regulation and drug development

Article Abstract:

Studies in protease-mediated cell signalling are discussed. Proteases generate hormone-like signals through various mechanisms, the most interesting of which is the mechanism involving proteolytically revealed tethered activating peptides which stimulate the thrombin receptor and protease-activating receptor 2. This protease-specific mechanism can also be compared to the nonspecific proteolytic activation of the insulin receptor.

Author: Hollenberg, Morley D.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1996
Analysis, Proteases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Similar abstracts:
  • Abstracts: Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics. The 5-HT(sub 4) receptor: a place in the sun
  • Abstracts: Breakthrough partnership. Percutaneous absorption of borates in human skin
  • Abstracts: The influence of endocardial endothelium on myocardial contraction. Myocardial preconditioning as the heart's self-protecting response against the consequences of ischaemia
  • Abstracts: Cloning and characterization of human chemokine receptors. Cloning of human prostanoid receptors
  • Abstracts: The race to control pain: more participants, more targets. Presenilin mutations in Alzheimer's disease: molecular models suggest a potential functional locus
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.